Search results
Jump to navigation
Jump to search
- ...Sloan-Kettering Cancer Center]], no studies of sheep sorrel alone, as an antineoplastic agent, have been done.1 KB (194 words) - 22:25, 19 August 2010
- {{r|Antineoplastic agent}}2 KB (219 words) - 21:43, 11 January 2010
- ...etabolite fluoropyrimidine analog of the nucleoside pyrimidine, used as an antineoplastic agent but also as an immunomodulator in dermatology.2 KB (318 words) - 02:18, 7 April 2024
- In [[medicine]], '''cetuximab''' (se tux' i mab) is an [[antineoplastic agent]] that is "an [[antibody]] that blocks [[epidermal growth factor receptor|r3 KB (353 words) - 01:59, 23 September 2010
- ...vastin''' by [[Genentech]], a subsidiary of [[Roche Laboratories]] as an [[antineoplastic agent]].3 KB (376 words) - 14:53, 17 July 2010
- ...relatively low prevalence of the disease, there is less experience with [[antineoplastic agent]]s and [[biologic response modifier]]s. More successful chemotherapy has us3 KB (421 words) - 13:28, 8 August 2010
- As a primary [[antineoplastic agent]], [[fludarabine]] may be more effective than [[chlorambucil]].<ref name="p4 KB (497 words) - 22:05, 12 June 2010
- ...d of the war, they proved to be the basis of some of the first effective [[antineoplastic agent]]s for [[cancer]] [[chemotherapy]].6 KB (979 words) - 11:49, 2 February 2023
- Bleomycin and carboplatin are the most common adjuvant and palliative [[antineoplastic agent]]s. As with any cancer chemotherapy, the challenge is managing the toxicity11 KB (1,557 words) - 00:26, 9 September 2010
- '''<sup>90</sup>Yttrium-Ibritumomab Tiuxetan''' is an [[antineoplastic agent]] indicated for [[non-Hodgkin’s lymphom]]a. <sup>90</sup>Y-Ibritumomab Ti11 KB (1,563 words) - 03:38, 7 October 2013
- *[[Antineoplastic agent/Definition]]15 KB (1,521 words) - 09:02, 2 March 2024